Benzinga | Jun 29, 2021 08:53AM EDT

Aligos Therapeutics Presses Capital Raise Button

* Aligos Therapeutics Inc (NASDAQ:ALGS) commenced an underwritten public offering of 4 million shares of common stock.

* Underwriters can purchase up to an additional 600k shares.

* J.P. Morgan, Jefferies, and Piper Sandler are acting as the joint book-running managers for the offering.

* Cantor is acting as a lead manager for the offering.

* The proceeds will be used to fund the clinical development of STOPS candidates and R&D activities for siRNA and NASH THR-? candidates.

* See the offering prospectus here.

* Price Action: ALGS shares are down 7.07% at $22.07 during the premarket session on the last check Tuesday.